Agnelli et al. reclassified 11% of PTCL-NOS cases as ALCL using a 3-gene model (TNFRSF8, BATF3, and TMOD1) with 97% accuracy (61). The gene discussed is TMOD1; the disease is mature T-cell and NK-cell non-Hodgkin lymphoma.